Rare Disease Assets Consolidation

搜索文档
BioCryst Pharmaceuticals (BCRX) 2025 Conference Transcript
2025-09-04 22:45
BioCryst Pharmaceuticals (BCRX) 2025 Conference September 04, 2025 09:45 AM ET Speaker0Good morning, everyone, and thanks so much for joining us for our next session. I'm Steve Seidos with the Cantor Biotech team. It's really a privilege to welcome our next participating company at the conference, BioCryst Pharmaceuticals. Thanks to everyone on the webcast and in the room for being here also. And I'm joined on stage by CFO, Bob R.Geiss and President and CEO CCO, excuse me, and guess there's a lot of change ...
BioCryst Pharmaceuticals(BCRX) - 2025 Q2 - Earnings Call Transcript
2025-08-04 21:32
BioCryst Pharmaceuticals (BCRX) Q2 2025 Earnings Call August 04, 2025 08:30 AM ET Company ParticipantsJohn Bluth - Chief Communications OfficerJon Stonehouse - CEOCharlie Gayer - President & Chief Commercial OfficerBabar Ghias - CFO & Head - Corporate DevelopmentLaura Chico - Managing DirectorSteve Seedhouse - Biotechnology Equity ResearchHelen Thackray - Chief Research & Development OfficerTazeen Ahmad - MD - US Equity ResearchGena Huidong Wang - Managing Director, Biotech Equity ResearchBrian Abrahams - M ...